Standard BioTools Inc. (LAB)

Standard BioTools Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	172.27	174.43	106.34	97.95	128.85	131.39
Other Revenue	-	-	-	-	1.73	6.76
Revenue	172.27	174.43	106.34	97.95	130.58	138.14
Revenue Growth (YoY)	26.39%	64.03%	8.57%	-24.99%	-5.47%	17.83%
Cost of Revenue	87.73	90.17	55.89	60.9	99.15	91.28
Gross Profit	84.54	84.26	50.45	37.05	31.43	46.87
Selling, General & Admin	163.26	156.61	87.54	102.29	98.89	97.9
Research & Development	59.22	62.41	25.95	33.86	-	-
Operating Expenses	222.48	219.02	113.49	136.14	98.89	97.9
Operating Income	-137.94	-134.76	-63.04	-99.09	-67.46	-51.04
Interest Expense	-1.44	-3.32	-4.57	-4.33	-3.82	-3.57
Interest & Investment Income	14.07	20.2	5.57	2.23	-	-
Other Non Operating Income (Expenses)	2.18	-5.17	1.39	-60.9	7.62	0.51
EBT Excluding Unusual Items	-123.13	-123.05	-60.64	-162.09	-63.66	-54.1
Merger & Restructuring Charges	-15.25	-40.48	-13.56	-13.59	-	-
Asset Writedown	-	-	-	-3.53	-	-
Other Unusual Items	-	25.21	-	-13.72	-	-
Pretax Income	-138.39	-138.31	-74.2	-192.93	-63.66	-54.1
Income Tax Expense	-0.31	0.57	0.45	-2.83	-4.42	-1.08
Net Income	-120.5	-138.89	-74.66	-190.1	-59.24	-53.02
Preferred Dividends & Other Adjustments	-	46.01	-	-	-	-
Net Income to Common	-120.5	-184.9	-74.66	-190.1	-59.24	-53.02
Shares Outstanding (Basic)	376	353	79	78	76	72
Shares Outstanding (Diluted)	376	353	79	78	76	72
Shares Change (YoY)	82.38%	346.24%	1.09%	3.32%	5.19%	7.88%
EPS (Basic)	-0.32	-0.52	-0.94	-2.43	-0.78	-0.74
EPS (Diluted)	-0.32	-0.52	-0.94	-2.43	-0.78	-0.74
Free Cash Flow	-105.46	-151.81	-46.12	-93.2	-57.33	-28.13
Free Cash Flow Per Share	-0.28	-0.43	-0.58	-1.19	-0.76	-0.39
Gross Margin	49.07%	48.31%	47.44%	37.83%	24.07%	33.92%
Operating Margin	-80.07%	-77.25%	-59.28%	-101.17%	-51.66%	-36.94%
Profit Margin	-69.95%	-106.00%	-70.20%	-194.08%	-45.36%	-38.38%
Free Cash Flow Margin	-61.22%	-87.03%	-43.37%	-95.15%	-43.90%	-20.37%
EBITDA	-121.97	-117.9	-47.86	-84.06	-63.81	-47.02
EBITDA Margin	-70.80%	-67.59%	-45.01%	-85.82%	-48.86%	-34.04%
D&A For EBITDA	15.98	16.86	15.18	15.03	3.65	4.01
EBIT	-137.94	-134.76	-63.04	-99.09	-67.46	-51.04
EBIT Margin	-80.07%	-77.25%	-59.28%	-101.17%	-51.66%	-36.94%
Revenue as Reported	172.27	174.43	106.34	97.95	130.58	138.14
Advertising Expenses	-	5.9	2	-	3.4	1.6

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q